Transsexualism: Clinical Trials

4 trials for Transsexualism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow Transsexualism: new trials by email Literature Review of Transsexualism trials Research Report on Transsexualism

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution - Transgenderism, Reproductive Issues
Phase 4RecruitingUniversity of California, San Diego802025-12-052026-01-15
Androgen Effects on the Reproductive Neuroendocrine Axis
Testosterone Cypionate 50 MG/ML Injectable Solution - Transgenderism, Reproductive Issues
Phase 4TerminatedUniversity of California, San Diego22025-02-262025-07-22
Drug-Drug Interaction Study in Trans Women Living With HIV
Biktarvy 50/200/25 Tab, Estradiol Tablets - Hiv, Transgenderism
Phase 4UnknownMaple Leaf Research452022-11-232024-09-26
Sex Steroids and the Serotonin Transporter
Testolactone undecanoate, Lynestrenol, Cyproterone Acetate - Transsexualism
Phase 4CompletedMedical University of Vienna322010-02-012014-01-03

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Gender Dysphoria (1)

Broader conditions

Behavior (4)  ·  Sexual Behavior (4)  ·  Sexuality (4)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Mental Disorders (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexual Dysfunctions, Psychological (1)

Interventions

Estradiol (2)  ·  5-alpha Reductase Inhibitors (1)  ·  Cyproterone Acetate (1)  ·  Lynestrenol (1)  ·  testosterone 17 beta-cypionate (1)  ·  testosterone undecanoate (1)

Sponsors

University of California, San Diego (2)  ·  Maple Leaf Research (1)  ·  Medical University of Vienna (1)

Countries

United States (2)  ·  Austria (1)  ·  Canada (1)

Top investigators

Antoni Duleba, MD (2)  ·  Mona Loutfy, MD, MPH (1)  ·  Rupert Lanzenberger, MD A/Prof (1)

Results publications

PMID 25497691

NIH funding

R01HD111650 (2)